Literature DB >> 33577242

The Viability and Growth of HaCaT Cells After Exposure to Bioactive Glass S53P4-Containing Cell Culture Media.

Jussi Sarin1,2, Minna Vuorenmaa2, Pekka K Vallittu3,4,5, Reidar Grénman1, Pia Boström6, Pilvi Riihilä7,8, Liisa Nissinen7,8, Veli-Matti Kähäri7,8, Jaakko Pulkkinen1.   

Abstract

HYPOTHESIS: Bioactive glass (BG) S53P4 reduces the viability of epidermal keratinocyte-derived immortalized cell line, HaCaT in sufficient concentrations in vitro.
BACKGROUND: Although used in mastoid obliteration surgery, there is no data available on whether BG S53P4 granules have an inhibitory or excitatory effect on keratinocytes, found in normal skin and ear cholesteatoma in vivo.
METHODS: HaCaT cell cultures were incubated with a direct BG S53P4 granule contact. Microscopic evaluation of the cultures was performed and interleukin-6 (IL-6) and -8 (IL-8) concentrations were measured from the medium samples. In addition, BG granules were incubated in two cell culture media for 6 days and the pure media were used in confluent HaCaT cultures preceding cell viability assay. Finally, a scratch assay test was performed to reveal the possible BG effect on HaCaT cultures.
RESULTS: Eight to ten cell thick layers of dead HaCaT cells were noticed after a 2-day BG granule contact. With a BG concentration of 2.5%, IL-6 and IL-8 concentrations were smaller compared with the control group without BG after 2 days' incubation. Overall, HaCaT cell viability decreased when BG was incubated in keratinocyte growth medium, but did not change in Dulbecco's modified Eagle's medium. In a scratch assay test, cell regrowth in the scratch area was notable in cultures without BG.
CONCLUSIONS: BG S53P4 seems to have an inhibitory effect on HaCaT cell growth. Although further studies are needed, this observation seems advantageous for cholesteatoma treatment.
Copyright © 2021, Otology & Neurotology, Inc.

Entities:  

Year:  2021        PMID: 33577242     DOI: 10.1097/MAO.0000000000003057

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  2 in total

1.  Cholesteatoma surgery in the pediatric population: remaining challenges in the era of mastoid obliteration.

Authors:  Victor J Kroon; Steven W Mes; Pepijn A Borggreven; Rick van de Langenberg; David R Colnot; Jasper J Quak
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-10-08       Impact factor: 3.236

2.  Antibiotics in mastoid and epitympanic obliteration with S53P4 bioactive glass: A retrospective study.

Authors:  Lauranne Alciato; Daniele Bernardeschi; Valérie Pourcher; Naira Mkrtchyan; Frédéric Tankéré; Olivier Sterkers; Ghizlène Lahlou
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-09-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.